Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports. Here’s a news alert from InsideHealthPolicy.com “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]
The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC. The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes. One exception, however, is tuberculosis. […]
Some of the greatest minds on TB gathered this week here in Rio de Janeiro, Brazil, where advocates, researchers, and donors from all over the world attended the Stop TB Partnership. TB is killing nearly 2 million people a year, yet still gets far too little attention, and the purpose of the conference was to […]
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]